Renal Cancers Completed Phase 2 Trials for Gemcitabine (DB00441)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00401128Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney CancerTreatment
NCT00003928Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney CancerTreatment
NCT00042965Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney CancerTreatment
NCT00058318S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) CancerTreatment
NCT00496587Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell CarcinomaTreatment